海外の治験の状況「1」での検索結果
11240件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- TopQ Cut-off Score Validation Study for 3D OCT-1 Maestro
- Subjects Presenting With Normal Eyes;Subjects Presenting With Normal Eyes;Subjects Presenting With Normal Eyes;Subjects Presenting With Normal Eyes
- United States
- 2015-05-11
Not recruiting
- A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA
- Iron Deficiency Anemia (IDA);Iron Deficiency Anemia (IDA);Iron Deficiency Anemia (IDA);Iron Deficiency Anemia (IDA)
- Poland, Russian Federation, United States
- 2015-03-27
Recruiting
- Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients
- HIV-1 Infection;Receipt of Cal-1 Modified Hematopoietic Cellular Products
- United States
- 2015-03-11
Not recruiting
- Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies
- Advanced Cancer;Advanced Malignancies;Advanced Cancer;Advanced Malignancies;Advanced Cancer;Advanced Malignancies;Advanced Cancer;Advanced Malignancies
- Australia, Spain, United States
- 2015-02-02
Recruiting
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 1
- Type1 Diabetes Mellitus;Type1 Diabetes Mellitus;Type1 Diabetes Mellitus;Type1 Diabetes Mellitus
- France, Italy, Netherlands, United States
- 2016-12-05
Recruiting
- Neurokinin (NK) 1 Antagonist for Pathological Aggression for Harmful, Impulsive, and Self-/Aggressive Behaviour
- Aggression;Aggression;Aggression
- Canada
- 2016-11-23
Not Recruiting
- EC122 HER-1 Prostate Phase I
- Hormone refractory prostate cancer;Prostatic Neoplasms
- Cuba
- 2016-11-15
Recruiting
- Day and Night Closed-loop in Young People With Type 1 Diabetes
- Diabetes Mellitus;Diabetes Mellitus, Type 1;Glucose Metabolism Disorders;Endocrine System Diseases;Autoimmune Diseases
- United Kingdom, United States
- 2016-10-04
Not recruiting
- Phase 1 Safety Study of Single and Multi-Dose Topically Applied OLT1177 Gel in Healthy Subjects
- Healthy Volunteers
- United States
- 2012-07-05
Not recruiting
- A Phase 1, Open-Label, 10 Day Safety Study
- Healthy Subjects;Healthy Subjects;Healthy Subjects;Healthy Subjects
- United States
- 2012-06-06